Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx.

Pharmaceutics·2026
Same author

Targeting SARS-CoV-2 Non-Structural Proteins: A Blueprint for Next-Generation Small-Molecule Coronavirus Antivirals.

Pharmaceutics·2026
Same author

Targeting SARS-CoV-2 Structural and Accessory Proteins: Emerging Opportunities for Small-Molecule Coronavirus Antivirals.

Pharmaceutics·2026
Same author

A receptor kinase complex refines cambium activity in <i>Arabidopsis</i>.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Proteome-wide quantification of inositol pyrophosphate-protein interactions.

Nature communications·2026
Same author

Structure, function, and applications of two novel phage recombinases from extreme environments.

Nucleic acids research·2026

Related Experiment Video

Updated: Jun 14, 2026

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
12:22

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

Published on: December 30, 2012

24.5K

Profiling Serine Hydrolases in the Leishmania Host-Pathogen Interactome Using Cell-Permeable Activity-Based

Jaime A Isern1, Exequiel O J Porta1, Karunakaran Kalesh2,3

  • 1Department of Chemistry, Durham University, Stockton Rd., Durham, DH1 3LE, UK.

Chembiochem : a European Journal of Chemical Biology
|March 27, 2025
PubMed
Summary

Activity-based protein profiling identified 14 serine hydrolases in Leishmania mexicana, revealing significant changes in their activity across parasite life stages. Inhibiting these enzymes reduced parasite infectivity, highlighting their role as virulence factors.

Keywords:
Leishmaniafluorophosphonate probeshost–pathogen interactomesproteomicsserine hydrolases

More Related Videos

Polysome Profiling in Leishmania, Human Cells and Mouse Testis
14:32

Polysome Profiling in Leishmania, Human Cells and Mouse Testis

Published on: April 8, 2018

17.9K
Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
08:17

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major

Published on: October 28, 2022

1.6K

Related Experiment Videos

Last Updated: Jun 14, 2026

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
12:22

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

Published on: December 30, 2012

24.5K
Polysome Profiling in Leishmania, Human Cells and Mouse Testis
14:32

Polysome Profiling in Leishmania, Human Cells and Mouse Testis

Published on: April 8, 2018

17.9K
Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
08:17

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major

Published on: October 28, 2022

1.6K

Area of Science:

  • Parasitology
  • Biochemistry
  • Neglected Tropical Diseases

Background:

  • Leishmaniasis is a neglected tropical disease caused by Leishmania parasites, posing a significant global health challenge.
  • Treatment is complicated by parasite lifecycle stages and increasing drug resistance.
  • Understanding parasite-host interactions is crucial for developing new therapies.

Purpose of the Study:

  • To investigate serine hydrolases (SHs) in Leishmania mexicana using activity-based protein profiling (ABPP).
  • To analyze SH activity across different parasite lifecycle stages.
  • To explore the role of SHs as potential virulence factors and therapeutic targets.

Main Methods:

  • Employed cell-permeable fluorophosphonate probes for ABPP in Leishmania mexicana.
  • Utilized secondary reactions with affinity reagents for analysis.
  • Compared SH activity across promastigote and amastigote stages.
  • Tested the effect of a prolyl-oligopeptidase inhibitor on parasite infectivity.

Main Results:

  • Identified 14 SHs, including peptidases and lipases, in the L. mexicana proteome.
  • Observed significant changes in SH activity across parasite lifecycle stages.
  • Demonstrated that SHs are important virulence factors.
  • Found that Z-Pro-Prolinal reduced parasite infectivity by altering multiple SH targets.

Conclusions:

  • Intracellular ABPP provides insights into the Leishmania host-parasite interactome.
  • SHs are critical virulence factors in Leishmania mexicana.
  • Targeting SHs, such as with prolyl-oligopeptidase inhibitors, may offer a strategy to reduce parasite infectivity.